Surface Oncology, Inc.
Antibodies that bind CD39 and uses thereof
Last updated:
Abstract:
The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
Status:
Grant
Type:
Utility
Filling date:
13 May 2020
Issue date:
6 Oct 2020